87
Participants
Start Date
October 18, 2024
Primary Completion Date
January 31, 2028
Study Completion Date
January 31, 2028
Drug: BG-T187
Intravenous administration
NOT_YET_RECRUITING
Seoul National University Bundang Hospital, BundangGu SeongnamSi
NOT_YET_RECRUITING
The Catholic University of Korea, St Vincents Hospital, PaldalGu SuwonSi
RECRUITING
Next Virginia, Fairfax
RECRUITING
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
NOT_YET_RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Harbin Medical University Cancer Hospital, Harbin
NOT_YET_RECRUITING
Linyi Peoples Hospital, Linyi
NOT_YET_RECRUITING
Tianjin Medical University Cancer Institute and Hospital, Tianjin
NOT_YET_RECRUITING
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
RECRUITING
Fujian Cancer Hospital, Fuzhou
RECRUITING
Chongqing University Cancer Hospital, Chongqing
RECRUITING
Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan
RECRUITING
Hubei Cancer Hospital, Wuhan
NOT_YET_RECRUITING
The Sixth Affiliated Hospital, Sun Yat Sen University, Guangzhou
RECRUITING
Guangxi Medical University Cancer Hospital, Nanning
RECRUITING
Hackensack University Medical Center, Hackensack
RECRUITING
The University of Texas Md Anderson Cancer Center, Houston
RECRUITING
Washington University, St Louis, Division of Oncology, Madison
RECRUITING
Blacktown Cancer and Haematology Centre, Blacktown
RECRUITING
Macquarie University, North Ryde
RECRUITING
Cabrini Hospital Malvern, Malvern East
RECRUITING
Linear Clinical Research, Nedlands
NOT_YET_RECRUITING
Affiliated Hospital of Hebei University, Baoding
NOT_YET_RECRUITING
Shanxi Bethune Hospital, Taiyuan
NOT_YET_RECRUITING
Samsung Medical Center, GangnamGu
NOT_YET_RECRUITING
The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu
NOT_YET_RECRUITING
Severance Hospital Yonsei University Health System, SeodaemunGu
NOT_YET_RECRUITING
Seoul National University Hospital, Seoul
NOT_YET_RECRUITING
Asan Medical Center, SongpaGu
Lead Sponsor
BeiGene
INDUSTRY